These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE, Sachdeo RC, Beydoun A, Glauser TA, Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Quality Standards Subcommittee of the American Academy of Neurology, American Epilepsy Society. Neurology; 2004 Apr 27; 62(8):1261-73. PubMed ID: 15111660 [Abstract] [Full Text] [Related]
12. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Llanas Park E, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J. Neurology; 2018 Jul 10; 91(2):74-81. PubMed ID: 29898971 [Abstract] [Full Text] [Related]
14. A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial. Marson AG, Appleton R, Baker GA, Chadwick DW, Doughty J, Eaton B, Gamble C, Jacoby A, Shackley P, Smith DF, Tudur-Smith C, Vanoli A, Williamson PR. Health Technol Assess; 2007 Oct 10; 11(37):iii-iv, ix-x, 1-134. PubMed ID: 17903391 [Abstract] [Full Text] [Related]
15. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs. White HS. Epilepsia; 1999 Oct 10; 40 Suppl 5():S2-10. PubMed ID: 10530688 [Abstract] [Full Text] [Related]
16. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. Wilby J, Kainth A, Hawkins N, Epstein D, McIntosh H, McDaid C, Mason A, Golder S, O'Meara S, Sculpher M, Drummond M, Forbes C. Health Technol Assess; 2005 Apr 10; 9(15):1-157, iii-iv. PubMed ID: 15842952 [Abstract] [Full Text] [Related]
17. New pharmacotherapies for pediatric seizures. Pellock JM. Pediatr Ann; 2004 Jun 10; 33(6):385-91. PubMed ID: 19449513 [No Abstract] [Full Text] [Related]
18. New antiepileptic drug therapies. Bergin AM, Connolly M. Neurol Clin; 2002 Nov 10; 20(4):1163-82. PubMed ID: 12616686 [Abstract] [Full Text] [Related]
19. Effects of antiepileptic drugs on cognition. Aldenkamp AP. Epilepsia; 2001 Nov 10; 42 Suppl 1():46-9, discussion 50-1. PubMed ID: 11422358 [No Abstract] [Full Text] [Related]